Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 14
23
Diseases
3,075
Unique genes
0.149
Avg. similarity score
Crohn disease
Most-connected disease (11 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Crohn disease
Inflammatory bowel disease
Psoriasis
Sclerosing cholangitis
Ulcerative colitis
Inflammatory skin disease
Ankylosing spondylitis
Eczema
Asthma
Psoriasis vulgaris
Respiratory system disease
Iga nephropathy
Obstructive pulmonary disease
Benign flecked retina
Multiple sclerosis
neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties
Autonomic nervous system disease
Intellectual developmental disorder neuropsychiatric
Psoriatic arthritis
Autoinflammatory disease, systemic, with vasculitis
Ehrlich tumor carcinoma
intellectual developmental disorder 59
neurodevelopmental disorder with spasticity, seizures, and brain abnormalities
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Crohn disease | 11 | 11 | 690 |
| Inflammatory bowel disease | 9 | 9 | 690 |
| Psoriasis | 9 | 9 | 731 |
| Sclerosing cholangitis | 9 | 9 | 230 |
| Ulcerative colitis | 9 | 9 | 611 |
| Inflammatory skin disease | 7 | 7 | 76 |
| Ankylosing spondylitis | 6 | 6 | 313 |
| Eczema | 6 | 6 | 365 |
| Asthma | 5 | 5 | 1,068 |
| Psoriasis vulgaris | 5 | 5 | 54 |
| Respiratory system disease | 5 | 5 | 241 |
| Iga nephropathy | 4 | 4 | 203 |
| Obstructive pulmonary disease | 4 | 4 | 559 |
| Benign flecked retina | 3 | 3 | 1 |
| Multiple sclerosis | 3 | 3 | 576 |
| neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties | 3 | 3 | 1 |
| Autonomic nervous system disease | 2 | 2 | 2 |
| Intellectual developmental disorder neuropsychiatric | 2 | 2 | 1 |
| Psoriatic arthritis | 2 | 2 | 73 |
| Autoinflammatory disease, systemic, with vasculitis | 1 | 1 | 1 |
| Ehrlich tumor carcinoma | 1 | 1 | 1 |
| intellectual developmental disorder 59 | 1 | 1 | 1 |
| neurodevelopmental disorder with spasticity, seizures, and brain abnormalities | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases ‐ top 100 shown, download for all)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HLA-B | 13 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 9 more |
| HLA-DQA1 | 13 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 9 more |
| RUNX3 | 13 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 9 more |
| ETS1 | 12 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 8 more |
| HLA-DQB1 | 12 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 8 more |
| IL2RA | 12 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 8 more |
| TNFAIP3 | 12 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 8 more |
| BACH2 | 11 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 7 more |
| EMSY | 11 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 7 more |
| HLA-DRB1 | 11 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 7 more |
| IKZF1 | 11 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 7 more |
| IL23R | 11 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory bowel disease and 7 more |
| IRF1 | 11 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 7 more |
| FAP | 10 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory bowel disease and 6 more |
| IFIH1 | 10 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory bowel disease and 6 more |
| IL18R1 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 6 more |
| NDFIP1 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 6 more |
| NOS2 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 6 more |
| PSMA6 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 6 more |
| SMAD3 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 6 more |
| STAT3 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 6 more |
| TAGAP | 10 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Iga nephropathy and 6 more |
| TNIP1 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 6 more |
| TTC33 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Iga nephropathy and 6 more |
| UBAC2 | 10 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 6 more |
| ANKRD55 | 9 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Iga nephropathy and 5 more |
| CAMK2G | 9 / 23 | Asthma, Crohn disease, Inflammatory bowel disease, intellectual developmental disorder 59 and 5 more |
| CCL20 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| CD28 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Iga nephropathy and 5 more |
| CLEC16A | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 5 more |
| ELMO1 | 9 / 23 | Autonomic nervous system disease, Crohn disease, Eczema, Inflammatory bowel disease and 5 more |
| HDAC7 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| IL2 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 5 more |
| JAK2 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| JAZF1 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| LTBR | 9 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 5 more |
| MYRF | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 5 more |
| NFKB1 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Iga nephropathy and 5 more |
| NOD2 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| PRR5L | 9 / 23 | Asthma, Crohn disease, Eczema, Inflammatory bowel disease and 5 more |
| PTPN2 | 9 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory bowel disease and 5 more |
| PTPRK | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| RMI2 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| RORC | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 5 more |
| SPMIP7 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 5 more |
| THEMIS | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| TMEM258 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 5 more |
| TNFRSF14 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| TSPAN14 | 9 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 5 more |
| TYK2 | 9 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 5 more |
| ZMIZ1 | 9 / 23 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 5 more |
| ASAP2 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Multiple sclerosis and 4 more |
| ATG5 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| ATXN2 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| CCDC88B | 8 / 23 | Crohn disease, Iga nephropathy, Inflammatory bowel disease, Multiple sclerosis and 4 more |
| CCL2 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| CD40 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| DNMT3A | 8 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 4 more |
| ERAP1 | 8 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory skin disease and 4 more |
| GRHL3 | 8 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory skin disease and 4 more |
| GSDMB | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| HLA-DOB | 8 / 23 | Asthma, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 4 more |
| IFNLR1 | 8 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory skin disease and 4 more |
| IL10 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| IL1R1 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 4 more |
| IL21 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 4 more |
| IL4R | 8 / 23 | Asthma, Crohn disease, Eczema, Inflammatory bowel disease and 4 more |
| IL6R | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 4 more |
| IL7R | 8 / 23 | Ankylosing spondylitis, Asthma, Eczema, Iga nephropathy and 4 more |
| ITGAL | 8 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Obstructive pulmonary disease and 4 more |
| KIF3B | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| LCE3A | 8 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory skin disease and 4 more |
| LCE3B | 8 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory skin disease and 4 more |
| LITAF | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| PDE4A | 8 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory bowel disease and 4 more |
| PLAU | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Iga nephropathy and 4 more |
| PLCL1 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| POFUT1 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| PTCD2 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| PUS10 | 8 / 23 | Ankylosing spondylitis, Crohn disease, Eczema, Inflammatory bowel disease and 4 more |
| RORA | 8 / 23 | Asthma, Crohn disease, Eczema, Iga nephropathy and 4 more |
| RPS26 | 8 / 23 | Asthma, Crohn disease, Eczema, Inflammatory bowel disease and 4 more |
| SBNO2 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Inflammatory bowel disease and 4 more |
| SETD1A | 8 / 23 | Ankylosing spondylitis, Crohn disease, Multiple sclerosis, Obstructive pulmonary disease and 4 more |
| SLC9A4 | 8 / 23 | Ankylosing spondylitis, Asthma, Crohn disease, Eczema and 4 more |
| STAT4 | 8 / 23 | Asthma, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 4 more |
| TAP2 | 8 / 23 | Ankylosing spondylitis, Asthma, Iga nephropathy, Inflammatory bowel disease and 4 more |
| TRAF3IP2 | 8 / 23 | Crohn disease, Eczema, Inflammatory bowel disease, Inflammatory skin disease and 4 more |
| TSBP1 | 8 / 23 | Asthma, Crohn disease, Eczema, Inflammatory bowel disease and 4 more |
| ZBTB38 | 8 / 23 | Asthma, Crohn disease, Eczema, Inflammatory bowel disease and 4 more |
| ADCY3 | 7 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| BLTP1 | 7 / 23 | Asthma, Crohn disease, Eczema, Inflammatory bowel disease and 3 more |
| BSN | 7 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Obstructive pulmonary disease and 3 more |
| C1ORF141 | 7 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 3 more |
| CARD9 | 7 / 23 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 3 more |
| CD226 | 7 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CD6 | 7 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Multiple sclerosis and 3 more |
| CDKAL1 | 7 / 23 | Ankylosing spondylitis, Crohn disease, Inflammatory bowel disease, Psoriasis and 3 more |
| CEBPA | 7 / 23 | Asthma, Crohn disease, Eczema, Inflammatory bowel disease and 3 more |
| CEP43 | 7 / 23 | Ankylosing spondylitis, Crohn disease, Iga nephropathy, Inflammatory bowel disease and 3 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Inflammatory bowel disease | KEGG | 58 / 66 | 3.4× | 1.88e-26 | 4.08e-23 ✓ sig. |
| Allograft rejection | KEGG | 36 / 39 | 3.6× | 1.67e-18 | 1.08e-15 ✓ sig. |
| Th17 cell differentiation | KEGG | 68 / 109 | 2.4× | 4.84e-16 | 1.99e-13 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 138 / 298 | 1.8× | 4.56e-15 | 1.55e-12 ✓ sig. |
| Type I diabetes mellitus | KEGG | 36 / 44 | 3.2× | 7.87e-15 | 2.54e-12 ✓ sig. |
| Th1 and Th2 cell differentiation | KEGG | 57 / 93 | 2.4× | 3.41e-13 | 7.95e-11 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 63 / 108 | 2.3× | 4.90e-13 | 1.12e-10 ✓ sig. |
| Leishmaniasis | KEGG | 50 / 78 | 2.5× | 8.13e-13 | 1.81e-10 ✓ sig. |
| Interleukin-10 signaling | Reactome | 35 / 47 | 2.9× | 2.95e-12 | 5.85e-10 ✓ sig. |
| Graft-versus-host disease | KEGG | 34 / 45 | 3.0× | 3.01e-12 | 5.94e-10 ✓ sig. |
| Asthma | KEGG | 27 / 32 | 3.3× | 4.79e-12 | 9.09e-10 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 36 / 50 | 2.8× | 7.63e-12 | 1.40e-9 ✓ sig. |
| Viral protein interaction with cytokine and cytokine receptor | KEGG | 56 / 100 | 2.2× | 8.94e-11 | 1.30e-8 ✓ sig. |
| Tuberculosis | KEGG | 86 / 181 | 1.9× | 1.33e-10 | 1.87e-8 ✓ sig. |
| Autoimmune thyroid disease | KEGG | 35 / 54 | 2.5× | 1.44e-9 | 1.53e-7 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| inflammatory response | GO:0006954 | 185 / 467 | 2.4× | 7.62e-34 | 5.33e-30 ✓ sig. |
| immune response | GO:0006955 | 197 / 543 | 2.2× | 6.03e-30 | 3.15e-26 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 76 / 161 | 2.9× | 7.17e-20 | 1.15e-16 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 319 / 1,208 | 1.6× | 7.49e-20 | 1.19e-16 ✓ sig. |
| cytokine-mediated signaling pathway | GO:0019221 | 69 / 145 | 2.9× | 2.09e-18 | 2.65e-15 ✓ sig. |
| cell surface receptor signaling pathway via JAK-STAT | GO:0007259 | 40 / 67 | 3.6× | 1.40e-15 | 1.06e-12 ✓ sig. |
| positive regulation of type II interferon production | GO:0032729 | 43 / 77 | 3.4× | 3.56e-15 | 2.55e-12 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 87 / 232 | 2.3× | 7.11e-15 | 4.70e-12 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 72 / 187 | 2.3× | 3.26e-13 | 1.65e-10 ✓ sig. |
| response to hypoxia | GO:0001666 | 68 / 176 | 2.3× | 1.22e-12 | 5.50e-10 ✓ sig. |
| positive regulation of cytokine production | GO:0001819 | 41 / 81 | 3.1× | 1.25e-12 | 5.66e-10 ✓ sig. |
| positive regulation of ERK1 and ERK2 cascade | GO:0070374 | 74 / 201 | 2.2× | 2.11e-12 | 9.00e-10 ✓ sig. |
| positive regulation of T cell activation | GO:0050870 | 28 / 45 | 3.8× | 6.16e-12 | 2.37e-9 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 200 / 778 | 1.6× | 1.33e-11 | 4.75e-9 ✓ sig. |
| positive regulation of interleukin-6 production | GO:0032755 | 46 / 103 | 2.7× | 1.56e-11 | 5.49e-9 ✓ sig. |